Optimization of clofibrate with natural product sesamol for reducing liver injury induced by acetaminophen-Reference-Cited by-同舟云学术

Optimization of clofibrate with natural product sesamol for reducing liver injury induced by acetaminophen

Published:2022-11-01 Issue:1 Volume:32 Page:38-46
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Han Chuchu,Zhang Linyang,Hua Yuxin,Liu Haitao,Liu Jiping,Shi Yongheng,Wang Xiaoping,Wang Wei,Jiang Yi,Zhang Huawei,Deng Chong,Xie Yundong,He Shipeng,Liu Ying

Funder

National Natural Science Foundation of China

The Natural Science Foundation of Shaanxi Province

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s00044-022-02989-6.pdf

Reference37 articles.

1. Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transplant. 2013;19:991–1000. https://doi.org/10.1002/lt.23688

2. Rizvi F, Mathur A, Kakkar P. Morin mitigates acetaminophen-induced liver injury by potentiating Nrf2 regulated survival mechanism through molecular intervention in PHLPP2-Akt-Gsk3β axis. Apoptosis. 2015;20:1296–306. https://doi.org/10.1007/s10495-015-1160-y

3. Masubuchi Y, Suda C, Horie T. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol. 2005;42:110–6. https://doi.org/10.1016/j.jhep.2004.09.015

4. Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther. 2000;67:591–9. https://doi.org/10.1067/mcp.2000.106574

5. del Mar Fernández de Gatta M, Calvo MV, Hernández JM, Caballero D. San Miguel JF, Domínguez-Gil A. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies. Clin Pharmacol Ther. 1996;60:332–40. https://doi.org/10.1016/S0009-9236(97)90148-X